Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > Starpharma Projects Receive ARC Grants

July 6th, 2004

Starpharma Projects Receive ARC Grants

Melbourne-based nanotechnology company Starpharma Holdings Limited has received peer endorsement of its dendrimer technology with the funding of two separate projects by the Australian Research Council. The projects will advance pharmaceutical applications of SPLís dendrimer technology by clarifying how dendrimers interact with drug targets, pathogens and other biological structures. The studies will receive a total of $440,000 over three years under the ARC scheme of competitive grants. (PDF)


Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 20th, 2018

Nanometrics to Present at the 30th Annual ROTH Conference February 27th, 2018

180 Degree Capital Corp. Reports Net Asset Value per Share of $2.60 as of December 31, 2017; A Decrease of 3.0% From Prior Quarter and an Increase of 11.1% From December 31, 2016 February 27th, 2018

Nanowire LED Innovator Aledia Announces Ä30 ($36M) Million Series-C Financing: Intel Capital Joins Existing Investors to Commercialize Certain Nanowire-LED Technologies for Mobile Displays January 29th, 2018

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project